Andrea van Elsas
2018
In 2018, Andrea van Elsas earned a total compensation of $2.2M as Chief Scientific Officer at Aduro BioTech, a 24% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $137,598 |
|---|---|
| Option Awards | $1,082,833 |
| Salary | $418,900 |
| Stock Awards | $538,625 |
| Total | $2,177,956 |
van Elsas received $1.1M in option awards, accounting for 50% of the total pay in 2018.
van Elsas also received $137.6K in non-equity incentive plan, $418.9K in salary and $538.6K in stock awards.
Rankings
In 2018, Andrea van Elsas' compensation ranked 5,285th out of 14,244 executives tracked by ExecPay. In other words, van Elsas earned more than 62.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,285 out of 14,244 | 63rd |
Division Manufacturing | 1,995 out of 5,765 | 65th |
Major group Chemicals And Allied Products | 729 out of 2,128 | 66th |
Industry group Drugs | 609 out of 1,817 | 67th |
Industry Pharmaceutical Preparations | 470 out of 1,391 | 66th |
Source: SEC filing on March 29, 2019.
van Elsas' colleagues
We found two more compensation records of executives who worked with Andrea van Elsas at Aduro BioTech in 2018.